✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
This research paper assessed theefficacy of high-dose nebulized IFN α 2b in severe COVID-19 pneumonia.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:The COVID-19 pandemic is progressing rapidly, sending the world into a great panic.
📊
Key Findings & Data:Healthcare professionals haveresponded by embarking on a concerted search for therapies to cure and prevent COVID-19.
💡
Conclusion & Impact:This research paper assessed theefficacy of high-dose nebulized IFN α 2b in severe COVID-19 pneumonia.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
The COVID-19 pandemic is progressing rapidly, sending the world into a great panic. Healthcare professionals haveresponded by embarking on a concerted search for therapies to cure and prevent COVID-19. Recently, interferon (IFN) has emerged as apotential therapy as it is associated with reducing lung inflammation and suppressing viral replication. This research paper assessed theefficacy of high-dose nebulized IFN α 2b in severe COVID-19 pneumonia.
🔖
Cite This Article
CHKHİS, A., ABDULRAZZAQ, N., MOKHTAR, S., JASMİ, A. A. (2021). Efficacy of High-Dose Nebulized Interferon α 2b in Severe COVID-19 Pneumonia. Turkish Thoracic Journal, Cilt: 22 - Sayı: 3, 199–204. https://ajindex.com/articles/395167